Index by author

January 01, 1994; Volume 61,Issue 1

  1. Para, Michael F.

    1. Antiviral therapy in HIV infection: practical guidelines
      Michael F. Para, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 76-77;

  2. Pashkow, Fredric J.

    1. Diagnostic evaluation of the patient with coronary artery disease
      Fredric J. Pashkow, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 43-48;

      Evaluation of patients with possible CAD involves balancing conflicting considerations, such as test sensitivity and accuracy, cost, and access.

  3. Patel, Sanat D.

    1. Intrahepatic cholestasis during nicotinic acid therapy
      Sanat D. Patel, MD and Harris C. Taylor, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 70-75;

  4. Pearce, Carolyn J.

    1. Labetalol and other agents that block both alpha- and beta-adrenergic receptors
      Donald G. Vidt, MD, Alan Bakst, PharmD, Carolyn J. Pearce, MD and J. David Wallin, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 59-69;

      A review of how these agents can be used in managing difficult-to-control hypertension.

  5. Pinski, Sergio L.

    1. Durability of bipolar coaxial endocardial pacemaker leads compared with unipolar leads
      Marcelo E. Helguera, MD, Sergio L. Pinski, MD, James D. Maloney, MD, Javier R. Woscoboinik, MD, Richard G. Trohman, MD, Victor A. Morant, MD, Bruce L. Wilkoff, MD and Lon W. Castle, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 25-28;

      Bipolar coaxial leads are preferable to unipolar leads in most aspects. Yet survival of bipolar coaxial leads in long-term follow-up studies seems worse than that of unipolar leads, indicating the need to reevaluate the risk-benefit ratio of the coaxial design.

  6. Pohl, Marc A.

    1. Changing the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease
      Marc A. Pohl, MD
      Cleveland Clinic Journal of Medicine January 1994, 61 (1) 38-42;

      An overview of the Collaborative Study Group trial, which found that ACE inhibition slows the loss of renal function in diabetes.

Back to top

In this issue